Long COVID-19: A Primer for Cardiovascular Health Professionals, on Behalf of the CCS Rapid Response Team

It is now widely recognized that COVID-19 illness can be associated with significant intermediate and potentially longer-term physical limitations. The term, “long COVID-19” is used to define any patient with persistent symptoms after acute COVID-19 infection (ie, after 4 weeks). It is postulated th...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Canadian journal of cardiology Ročník 37; číslo 8; s. 1260 - 1262
Hlavní autoři: Paterson, Ian, Ramanathan, Krishnan, Aurora, Rakesh, Bewick, David, Chow, Chi-Ming, Clarke, Brian, Cowan, Simone, Ducharme, Anique, Gin, Kenneth, Graham, Michelle, Gupta, Anil, Jassal, Davinder S., Kazmi, Mustapha, Krahn, Andrew, Lamarche, Yoan, Marelli, Ariane, Roifman, Idan, Ruel, Marc, Singh, Gurmeet, Sterns, Larry, Turgeon, Ricky, Virani, Sean, Wong, Kenny K., Zieroth, Shelley
Médium: Journal Article
Jazyk:angličtina
Vydáno: Elsevier Inc 01.08.2021
Canadian Cardiovascular Society. Published by Elsevier Inc
Témata:
Training/Practice Contemporary Issues in Cardiology Practice
ISSN:0828-282X, 1916-7075, 1916-7075
On-line přístup:Získat plný text
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!
Abstract It is now widely recognized that COVID-19 illness can be associated with significant intermediate and potentially longer-term physical limitations. The term, “long COVID-19” is used to define any patient with persistent symptoms after acute COVID-19 infection (ie, after 4 weeks). It is postulated that cardiac injury might be linked to symptoms that persist after resolution of acute infection, as part of this syndrome. The Canadian Cardiovascular Society Rapid Response Team has generated this document to provide guidance to health care providers on the optimal management of patients with suspected cardiac complications of long COVID-19. Il est désormais largement reconnu que la COVID-19 peut être associée à d'importantes limitations physiques à moyen terme et, potentiellement, à plus long terme. Le terme « COVID-19 longue » est utilisé pour décrire tout patient présentant des symptômes persistants après une infection aiguë par le virus de la COVID-19 (soit au-delà de quatre semaines). On suppose qu'une atteinte cardiaque pourrait être liée aux symptômes qui persistent après la disparition de l'infection aiguë, dans le cadre de ce syndrome. Le Groupe de travail sur la réaction rapide à la COVID-19 de la Société canadienne de cardiologie a produit le présent document afin de fournir des conseils aux professionnels de la santé sur la prise en charge optimale des patients chez qui l'on soupçonne des complications cardiaques causées par la COVID-19 longue.
AbstractList It is now widely recognized that COVID-19 illness can be associated with significant intermediate and potentially longer-term physical limitations. The term, "long COVID-19" is used to define any patient with persistent symptoms after acute COVID-19 infection (ie, after 4 weeks). It is postulated that cardiac injury might be linked to symptoms that persist after resolution of acute infection, as part of this syndrome. The Canadian Cardiovascular Society Rapid Response Team has generated this document to provide guidance to health care providers on the optimal management of patients with suspected cardiac complications of long COVID-19.It is now widely recognized that COVID-19 illness can be associated with significant intermediate and potentially longer-term physical limitations. The term, "long COVID-19" is used to define any patient with persistent symptoms after acute COVID-19 infection (ie, after 4 weeks). It is postulated that cardiac injury might be linked to symptoms that persist after resolution of acute infection, as part of this syndrome. The Canadian Cardiovascular Society Rapid Response Team has generated this document to provide guidance to health care providers on the optimal management of patients with suspected cardiac complications of long COVID-19.
It is now widely recognized that COVID-19 illness can be associated with significant intermediate and potentially longer-term physical limitations. The term, “long COVID-19” is used to define any patient with persistent symptoms after acute COVID-19 infection (ie, after 4 weeks). It is postulated that cardiac injury might be linked to symptoms that persist after resolution of acute infection, as part of this syndrome. The Canadian Cardiovascular Society Rapid Response Team has generated this document to provide guidance to health care providers on the optimal management of patients with suspected cardiac complications of long COVID-19.
It is now widely recognized that COVID-19 illness can be associated with significant intermediate and potentially longer-term physical limitations. The term, “long COVID-19” is used to define any patient with persistent symptoms after acute COVID-19 infection (ie, after 4 weeks). It is postulated that cardiac injury might be linked to symptoms that persist after resolution of acute infection, as part of this syndrome. The Canadian Cardiovascular Society Rapid Response Team has generated this document to provide guidance to health care providers on the optimal management of patients with suspected cardiac complications of long COVID-19. Il est désormais largement reconnu que la COVID-19 peut être associée à d'importantes limitations physiques à moyen terme et, potentiellement, à plus long terme. Le terme « COVID-19 longue » est utilisé pour décrire tout patient présentant des symptômes persistants après une infection aiguë par le virus de la COVID-19 (soit au-delà de quatre semaines). On suppose qu'une atteinte cardiaque pourrait être liée aux symptômes qui persistent après la disparition de l'infection aiguë, dans le cadre de ce syndrome. Le Groupe de travail sur la réaction rapide à la COVID-19 de la Société canadienne de cardiologie a produit le présent document afin de fournir des conseils aux professionnels de la santé sur la prise en charge optimale des patients chez qui l'on soupçonne des complications cardiaques causées par la COVID-19 longue.
Author Paterson, Ian
Ruel, Marc
Kazmi, Mustapha
Krahn, Andrew
Singh, Gurmeet
Gin, Kenneth
Jassal, Davinder S.
Turgeon, Ricky
Lamarche, Yoan
Marelli, Ariane
Zieroth, Shelley
Cowan, Simone
Ducharme, Anique
Clarke, Brian
Roifman, Idan
Ramanathan, Krishnan
Chow, Chi-Ming
Wong, Kenny K.
Gupta, Anil
Aurora, Rakesh
Bewick, David
Sterns, Larry
Virani, Sean
Graham, Michelle
Author_xml – sequence: 1
  givenname: Ian
  surname: Paterson
  fullname: Paterson, Ian
  organization: Division of Cardiology, University of Alberta, Edmonton, Alberta, Canada
– sequence: 2
  givenname: Krishnan
  surname: Ramanathan
  fullname: Ramanathan, Krishnan
  organization: Center for Cardiovascular Innovation, Division of Cardiology, University of British Colombia, Vancouver, British Columbia, Canada
– sequence: 3
  givenname: Rakesh
  surname: Aurora
  fullname: Aurora, Rakesh
  organization: Section of Cardiac Surgery, Max Rady College of Medicine, University of Manitoba, Winnipeg, Manitoba, Canada
– sequence: 4
  givenname: David
  surname: Bewick
  fullname: Bewick, David
  organization: Saint John Regional Hospital, Saint John, New Brunswick, Canada
– sequence: 5
  givenname: Chi-Ming
  surname: Chow
  fullname: Chow, Chi-Ming
  organization: Department of Medicine, University of Toronto, Division of Cardiology, Department of Medicine, St Michael's Hospital, Toronto, Ontario, Canada
– sequence: 6
  givenname: Brian
  surname: Clarke
  fullname: Clarke, Brian
  organization: Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada
– sequence: 7
  givenname: Simone
  surname: Cowan
  fullname: Cowan, Simone
  organization: Center for Cardiovascular Innovation, Division of Cardiology, University of British Colombia, Vancouver, British Columbia, Canada
– sequence: 8
  givenname: Anique
  surname: Ducharme
  fullname: Ducharme, Anique
  organization: Montreal Heart Institute, University of Montreal, Montreal, Quebec, Canada
– sequence: 9
  givenname: Kenneth
  surname: Gin
  fullname: Gin, Kenneth
  organization: Center for Cardiovascular Innovation, Division of Cardiology, University of British Colombia, Vancouver, British Columbia, Canada
– sequence: 10
  givenname: Michelle
  surname: Graham
  fullname: Graham, Michelle
  organization: Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada
– sequence: 11
  givenname: Anil
  surname: Gupta
  fullname: Gupta, Anil
  organization: Trillium Health Partners, Mississauga, Ontario, Canada
– sequence: 12
  givenname: Davinder S.
  surname: Jassal
  fullname: Jassal, Davinder S.
  organization: St Boniface Hospital, University of Manitoba, Winnipeg, Manitoba, Canada
– sequence: 13
  givenname: Mustapha
  surname: Kazmi
  fullname: Kazmi, Mustapha
  organization: Libin Cardiovascular Institute, University of Calgary, Calgary, Alberta, Canada
– sequence: 14
  givenname: Andrew
  surname: Krahn
  fullname: Krahn, Andrew
  organization: Center for Cardiovascular Innovation, Division of Cardiology, University of British Colombia, Vancouver, British Columbia, Canada
– sequence: 15
  givenname: Yoan
  surname: Lamarche
  fullname: Lamarche, Yoan
  organization: Department of Surgery, Institut de cardiologie de Montréal, Université de Montréal, Montreal, Quebec, Canada
– sequence: 16
  givenname: Ariane
  surname: Marelli
  fullname: Marelli, Ariane
  organization: McGill University Health Centre, Montreal, Quebec, Canada
– sequence: 17
  givenname: Idan
  surname: Roifman
  fullname: Roifman, Idan
  organization: Sunnybrook Health Sciences Centre, Department of Medicine, University of Toronto, Toronto, Ontario, Canada
– sequence: 18
  givenname: Marc
  surname: Ruel
  fullname: Ruel, Marc
  organization: University of Ottawa Heart Institute, Ottawa, Ontario, Canada
– sequence: 19
  givenname: Gurmeet
  surname: Singh
  fullname: Singh, Gurmeet
  organization: Mazankowski Alberta Heart Institute, University of Alberta, Edmonton, Alberta, Canada
– sequence: 20
  givenname: Larry
  surname: Sterns
  fullname: Sterns, Larry
  organization: Royal Jubilee Hospital, Victoria, British Columbia, Canada
– sequence: 21
  givenname: Ricky
  surname: Turgeon
  fullname: Turgeon, Ricky
  organization: Faculty of Pharmaceutical Sciences, University of British Columbia, Vancouver, British Columbia, Canada
– sequence: 22
  givenname: Sean
  surname: Virani
  fullname: Virani, Sean
  organization: Center for Cardiovascular Innovation, Division of Cardiology, University of British Colombia, Vancouver, British Columbia, Canada
– sequence: 23
  givenname: Kenny K.
  surname: Wong
  fullname: Wong, Kenny K.
  organization: IWK Health, Dalhousie University, Halifax, Nova Scotia, Canada
– sequence: 24
  givenname: Shelley
  orcidid: 0000-0002-6145-9814
  surname: Zieroth
  fullname: Zieroth, Shelley
  email: szieroth@sbgh.mb.ca
  organization: Cardiac Sciences Manitoba, University of Manitoba, Winnipeg, Manitoba, Canada
BookMark eNqFkc1vEzEQxS1URNPCP8DJRw7sMl7vh7dCSGX5aKVIRSVC3CzHnm0cHDvYm0j973GUcqCHcprDvN_TzHtn5MQHj4S8ZlAyYO27danXWpUVVKyEpgTGnpEZ61lbdNA1J2QGohJFJaqfp-QspTVAzbqufUFOeQ099AJmxM6Dv6PDzY_rTwXrL-gl_RbtBiMdQ6SDisaGvUp651SkV6jctMqCMGJKNnjl0lsaPP2IK-VGGkY6rZAOw3d6q7bW0FtM2-AT0gWqzUvyfMwAvnqY52Tx5fNiuCrmN1-vh8t5oWvBp6IFUKrVI-_rCrHBvukEaMa6GsW4BGWMMiMX_cgqrSttuIHOGLFUetnrvuPn5MPRdrtbbtBo9FNUTm7zVyrey6Cs_Hfj7Urehb0UTACveTZ482AQw-8dpklubNLonPIYdklWDRdQN7yBLBVHqY4hpYij1HZSU04mO1snGchDUXItD0XJQ1ESGpmLymj1CP174ZPQ-yOEOb-9xSiTtug1GhtRT9IE-zR-8QjXznqrlfuF9_-D_wAfLMEC
CitedBy_id crossref_primary_10_7759_cureus_59478
crossref_primary_10_1186_s12888_022_04497_8
crossref_primary_10_1016_j_cjca_2022_12_002
crossref_primary_10_1016_j_sxmr_2021_11_001
crossref_primary_10_1016_j_cjca_2023_04_003
crossref_primary_10_12688_f1000research_132098_2
crossref_primary_10_12688_f1000research_132098_1
crossref_primary_10_1515_jom_2024_0109
crossref_primary_10_1093_cvr_cvac115
crossref_primary_10_3389_fphys_2022_833650
crossref_primary_10_1016_j_cjca_2023_01_031
crossref_primary_10_1080_07853890_2023_2258902
crossref_primary_10_1016_j_ejrad_2022_110164
Cites_doi 10.3390/diseases8040040
10.1001/jamacardio.2020.3557
10.1016/j.jacc.2020.11.031
10.1093/eurheartj/ehab075
ContentType Journal Article
Copyright 2021 Canadian Cardiovascular Society
Copyright © 2021 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.
2021 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved. 2021 Canadian Cardiovascular Society
Copyright_xml – notice: 2021 Canadian Cardiovascular Society
– notice: Copyright © 2021 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved.
– notice: 2021 Canadian Cardiovascular Society. Published by Elsevier Inc. All rights reserved. 2021 Canadian Cardiovascular Society
DBID AAYXX
CITATION
7X8
5PM
DOI 10.1016/j.cjca.2021.05.011
DatabaseName CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Database_xml – sequence: 1
  dbid: 7X8
  name: MEDLINE - Academic
  url: https://search.proquest.com/medline
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1916-7075
EndPage 1262
ExternalDocumentID PMC8180343
10_1016_j_cjca_2021_05_011
S0828282X21002877
GroupedDBID ---
--K
--M
.1-
.FO
.GJ
.~1
0R~
1P~
1~.
1~5
29B
4.4
457
4G.
53G
5GY
5RE
5VS
6J9
7-5
8P~
AAEDT
AAEDW
AAFWJ
AAIKJ
AAKOC
AALRI
AAOAW
AAQFI
AATTM
AAXKI
AAXUO
AAYWO
ABBQC
ABFNM
ABJNI
ABLJU
ABMAC
ABMZM
ABWVN
ABXDB
ACDAQ
ACGFO
ACIEU
ACJTP
ACLOT
ACRLP
ACRPL
ACVFH
ADBBV
ADCNI
ADEZE
ADMUD
ADNMO
ADVLN
AEBSH
AEIPS
AEKER
AENEX
AEUPX
AEVXI
AFJKZ
AFPUW
AFRHN
AFTJW
AFXBA
AFXIZ
AGHFR
AGUBO
AGYEJ
AIEXJ
AIGII
AIIUN
AIKHN
AITUG
AJRQY
AJUYK
AKBMS
AKRWK
AKYEP
ALMA_UNASSIGNED_HOLDINGS
AMRAJ
ANKPU
ANZVX
APXCP
AXJTR
BKOJK
BLXMC
BNPGV
E3Z
EBS
EFJIC
EFKBS
EFLBG
EJD
F5P
FDB
FEDTE
FIRID
FNPLU
FYGXN
GBLVA
HVGLF
HX~
HYE
HZ~
J1W
KOM
M41
MO0
O-L
O9-
OAUVE
OA~
OK1
OL0
P-8
P-9
P2P
PC.
Q38
ROL
RPM
SDF
SEL
SES
SJN
SNG
SPCBC
SSH
SSZ
T5K
TR2
Z5R
~G-
~HD
AACTN
AAIAV
ABLVK
ABYKQ
AFCTW
AFKWA
AISVY
AJBFU
AJOXV
AMFUW
LCYCR
NAHTW
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c483t-600aa6cf3942ee5e95780c1174e8fb0addadf389f12cc2cd3d07dd8bacb9c973
ISICitedReferencesCount 15
ISICitedReferencesURI http://www.webofscience.com/api/gateway?GWVersion=2&SrcApp=Summon&SrcAuth=ProQuest&DestLinkType=CitingArticles&DestApp=WOS_CPL&KeyUT=000689316000022&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
ISSN 0828-282X
1916-7075
IngestDate Tue Sep 30 15:10:13 EDT 2025
Thu Oct 02 10:27:18 EDT 2025
Tue Nov 18 22:32:08 EST 2025
Thu Oct 16 04:33:56 EDT 2025
Fri Feb 23 02:43:56 EST 2024
Tue Oct 14 19:31:36 EDT 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 8
Language English
License Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c483t-600aa6cf3942ee5e95780c1174e8fb0addadf389f12cc2cd3d07dd8bacb9c973
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
ObjectType-Instructional Material/Guideline-3
content type line 23
Ian Paterson and Krishnan Ramanathan are co-first authors.
ORCID 0000-0002-6145-9814
OpenAccessLink https://pubmed.ncbi.nlm.nih.gov/PMC8180343
PMID 34090980
PQID 2538045350
PQPubID 23479
PageCount 3
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_8180343
proquest_miscellaneous_2538045350
crossref_citationtrail_10_1016_j_cjca_2021_05_011
crossref_primary_10_1016_j_cjca_2021_05_011
elsevier_sciencedirect_doi_10_1016_j_cjca_2021_05_011
elsevier_clinicalkey_doi_10_1016_j_cjca_2021_05_011
PublicationCentury 2000
PublicationDate 2021-08-01
PublicationDateYYYYMMDD 2021-08-01
PublicationDate_xml – month: 08
  year: 2021
  text: 2021-08-01
  day: 01
PublicationDecade 2020
PublicationTitle Canadian journal of cardiology
PublicationYear 2021
Publisher Elsevier Inc
Canadian Cardiovascular Society. Published by Elsevier Inc
Publisher_xml – name: Elsevier Inc
– name: Canadian Cardiovascular Society. Published by Elsevier Inc
References Kotecha, Knight, Razvi (bib0005) 2021; 42
Prasitlumkum, Chokesuwattanaskul, Thongprayoon (bib0001) 2020; 8
Puntmann, Carerj, Wieters (bib0004) 2020; 5
Kawakami, Sakamoto, Kawai (bib0003) 2021; 77
Parohan, Yaghoubi, Seraji (bib0002) 2020; 9
Prasitlumkum (10.1016/j.cjca.2021.05.011_bib0001) 2020; 8
Kawakami (10.1016/j.cjca.2021.05.011_bib0003) 2021; 77
Parohan (10.1016/j.cjca.2021.05.011_bib0002) 2020; 9
Kotecha (10.1016/j.cjca.2021.05.011_bib0005) 2021; 42
Puntmann (10.1016/j.cjca.2021.05.011_bib0004) 2020; 5
References_xml – volume: 8
  start-page: 40
  year: 2020
  ident: bib0001
  article-title: Incidence of myocardial injury in COVID-19-infected patients: a systematic review and meta-analysis
  publication-title: Diseases
– volume: 42
  start-page: 1866
  year: 2021
  end-page: 1878
  ident: bib0005
  article-title: Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance
  publication-title: Eur Heart J
– volume: 9
  start-page: 665
  year: 2020
  end-page: 677
  ident: bib0002
  article-title: Cardiac injury is associated with severe outcome and death in patients with coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies
  publication-title: Eur Heart J Acute Cardiovasc Care
– volume: 77
  start-page: 314
  year: 2021
  end-page: 325
  ident: bib0003
  article-title: Pathological evidence for SARS-CoV-2 as a cause of myocarditis: JACC Review Topic of the Week
  publication-title: J Am Coll Cardiol
– volume: 5
  start-page: 1265
  year: 2020
  end-page: 1273
  ident: bib0004
  article-title: Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19)
  publication-title: JAMA Cardiol
– volume: 8
  start-page: 40
  year: 2020
  ident: 10.1016/j.cjca.2021.05.011_bib0001
  article-title: Incidence of myocardial injury in COVID-19-infected patients: a systematic review and meta-analysis
  publication-title: Diseases
  doi: 10.3390/diseases8040040
– volume: 5
  start-page: 1265
  year: 2020
  ident: 10.1016/j.cjca.2021.05.011_bib0004
  article-title: Outcomes of cardiovascular magnetic resonance imaging in patients recently recovered from coronavirus disease 2019 (COVID-19)
  publication-title: JAMA Cardiol
  doi: 10.1001/jamacardio.2020.3557
– volume: 9
  start-page: 665
  year: 2020
  ident: 10.1016/j.cjca.2021.05.011_bib0002
  article-title: Cardiac injury is associated with severe outcome and death in patients with coronavirus disease 2019 (COVID-19) infection: a systematic review and meta-analysis of observational studies
  publication-title: Eur Heart J Acute Cardiovasc Care
– volume: 77
  start-page: 314
  year: 2021
  ident: 10.1016/j.cjca.2021.05.011_bib0003
  article-title: Pathological evidence for SARS-CoV-2 as a cause of myocarditis: JACC Review Topic of the Week
  publication-title: J Am Coll Cardiol
  doi: 10.1016/j.jacc.2020.11.031
– volume: 42
  start-page: 1866
  year: 2021
  ident: 10.1016/j.cjca.2021.05.011_bib0005
  article-title: Patterns of myocardial injury in recovered troponin-positive COVID-19 patients assessed by cardiovascular magnetic resonance
  publication-title: Eur Heart J
  doi: 10.1093/eurheartj/ehab075
SSID ssj0041776
Score 2.399651
Snippet It is now widely recognized that COVID-19 illness can be associated with significant intermediate and potentially longer-term physical limitations. The term,...
SourceID pubmedcentral
proquest
crossref
elsevier
SourceType Open Access Repository
Aggregation Database
Enrichment Source
Index Database
Publisher
StartPage 1260
SubjectTerms Training/Practice Contemporary Issues in Cardiology Practice
Title Long COVID-19: A Primer for Cardiovascular Health Professionals, on Behalf of the CCS Rapid Response Team
URI https://www.clinicalkey.com/#!/content/1-s2.0-S0828282X21002877
https://dx.doi.org/10.1016/j.cjca.2021.05.011
https://www.proquest.com/docview/2538045350
https://pubmed.ncbi.nlm.nih.gov/PMC8180343
Volume 37
WOSCitedRecordID wos000689316000022&url=https%3A%2F%2Fcvtisr.summon.serialssolutions.com%2F%23%21%2Fsearch%3Fho%3Df%26include.ft.matches%3Dt%26l%3Dnull%26q%3D
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVESC
  databaseName: Elsevier SD Freedom Collection Journals 2021
  customDbUrl:
  eissn: 1916-7075
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0041776
  issn: 0828-282X
  databaseCode: AIEXJ
  dateStart: 20171101
  isFulltext: true
  titleUrlDefault: https://www.sciencedirect.com
  providerName: Elsevier
link http://cvtisr.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1Za9tAEF6cpIS8lJ7EPcIW-pYqSCsrK_XNVVOakqQmDcVvYrVaEbuObHyE_PlCZ_aQpdCmB_RF2JJWx87n2W_X38wQ8popLrjIUamGITlx6XsixImrDAqFGS4TpauWnPCzs3g4TAadzncXC3M94VUV39wks_9qatgHxsbQ2b8wd31R2AGfweiwBbPD9o8Mf4LVg9LPX4_fe0FiAs8HmMN_rhWFaVt_aqOQBo0EHdqwgAnMnDgpnYYgTb_sn4vZCKMZtapWYTLoqya3rRMdNLJRSH275sr9QCw1ydfOaQ3Nc4E6WlzHd67nslof7a_m07mhueKbWtRL2O-UqwS_1ubbJQwW1AI6qyRyj3erC6xu9aCOENCUvI7EaQlFMROfB9PHoRnXjDMH6utx31Rmcd7epJixqI4brjtgprCBpQHwlf10iDGrHeMDOZaYt4oFJvNr0DwZjDu70vgKYf7sJ7G_Hm5rEeTgNMVA-7AXbpAtxqMEnPJW__ho-MlRiV7AdXXE-uVs1JcRKN5-gB2y7e72K5LVmES1JcANTnXxgNy3kyHaNyB-SDqqekS2T63c4zEZIZapw_Jb2qcGyRSQTNtmpAbJtIXkN3RaUYNjOi0p4JgCjqnGMXU4pojjJ-Tiw9FF-tGztUE82YvDpQc8XYhDWYZJjykVqQRGHvAvML9WcZn7MGqLogQyXgZMSiaLsPB5UcS5kHkiEx4-JZvVtFK7hMqg5FGQM3EIbBauIkSvLBIFPRnluHzSJYHry0zavPlYvmWSOYHkOENTZGiKzI8yMEWX7NdtZiZrzJ1nh85EmYuHhhE8A8Td2SqqW1m2bFjwb9u9cijIYCjB_wdFpaarRcaA_MAML4z8LuEteNQvgcno20eq0aVOSm-h_OyfWz4nO2vf8IJsLucr9ZLck9fL0WK-Rzb4MN6zv48fl-EGbw
linkProvider Elsevier
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Long+COVID-19%3A+A+Primer+for+Cardiovascular+Health+Professionals%2C+on+Behalf+of+the+CCS+Rapid+Response+Team&rft.jtitle=Canadian+journal+of+cardiology&rft.au=Paterson%2C+Ian&rft.au=Ramanathan%2C+Krishnan&rft.au=Aurora%2C+Rakesh&rft.au=Bewick%2C+David&rft.date=2021-08-01&rft.pub=Canadian+Cardiovascular+Society.+Published+by+Elsevier+Inc&rft.issn=0828-282X&rft.eissn=1916-7075&rft.volume=37&rft.issue=8&rft.spage=1260&rft.epage=1262&rft_id=info:doi/10.1016%2Fj.cjca.2021.05.011&rft_id=info%3Apmid%2F34090980&rft.externalDocID=PMC8180343
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0828-282X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0828-282X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0828-282X&client=summon